ECOG: The Eastern Cooperative Oncology Group

ECOG Protocols Active as of 03/11/10

Click on the protocol number to view the NCI's PDQ description of the protocol.

MELANOMA COMMITTEE


ProtocolTitle
E1697 Phase III Randomized Study of Four Weeks High Dose IFN-A2B in Stage T2B NO, T3A-B NO, T4A-B NO, and T1-4, N1A, 2A (microscopic) Melanoma
Activation Date: 22-dec-1998
E2602 A Phase II Study of Low Dose Peginterferon Alfa-2b in Patients with Metastatic Melanoma Over-Expressing Basic Fibroblast Growth Factor.
Activation Date: 05-sep-2003
ECOG Participants(requires Adobe Acrobat)
E2607 A Phase II Trial of Dasatinib in Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral and Solar Melanomas
Activation Date: 01-may-2009
ECOG Participants(requires Adobe Acrobat)

ECOG Home Page

How to contact ECOG

All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 03/11/10